Europe approves first mRNA flu-COVID vaccine, US remains on sidelines
The EU has cleared Moderna’s dual mRNA vaccine for seasonal flu and COVID-19, setting a global precedent. Meanwhile, US regulators have yet to grant authorization despite development occurring on American soil.